发明名称 |
FUSION PROTEINS COMPRISING MODIFIED ALPHA VIRUS SURFACE GLYCOPROTEINS AND TUMOR ASSOCIATED ANTIGEN AND METHODS THEREOF |
摘要 |
The present disclosure relates to fusion proteins that comprise one or more modified alpha virus surface glycoproteins and one or more tumor specific antigens. Also disclosed are fusion proteins that comprise one or more modified alpha virus surface glycoproteins and one or more viral specific antigens. Also disclosed are fusion proteins that comprise one or more modified alpha virus surface glycoproteins. It also relates to methods to activate the immune system in cancer patients to infiltrate and kill tumor cells or cells infected with a latent virus. The present disclosure provides a platform technology that elicits a faster, broader and stronger immune response using the fusion proteins. |
申请公布号 |
WO2016149643(A3) |
申请公布日期 |
2016.12.01 |
申请号 |
WO2016US23203 |
申请日期 |
2016.03.18 |
申请人 |
OMNICYTE |
发明人 |
LEONARDI, Peter;POLA, Elin, Martina;BABAD, Jeffrey |
分类号 |
A61K39/00;A61K39/12;A61P35/00;A61P37/04;C12N15/63 |
主分类号 |
A61K39/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|